DNA methyltransferases, DNA damage repair, and cancer

Advances in Experimental Medicine and Biology

Volumn 754, Issue , 2013, Pages 3-29

  Jin, Bilian ^a   Robertson, Keith D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

CARCINOGENESIS; CHROMOSOME; DEVELOPMENT; DNA METHYLATION; DNA REPAIR; EPIGENETICS; EXCISION REPAIR; GENE MUTATION; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE; WERNER SYNDROME;

EID: 84869046975     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9967-2_1     Document Type: Review

References (147)

1. Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6(8):597-610 (Pubitemid 41044297)
2. Kareta MS, Botello ZM, Ennis JJ, Chou C, Chedin F (2006) Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L. J Biol Chem 281(36): 25893-25902 (Pubitemid 44401795)
3. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247-257 (Pubitemid 29519904)
4. Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19(3):219-220 (Pubitemid 28309328)
5. Egger G, Jeong S, Escobar SG et al (2006) Identi fi cation of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc Natl Acad Sci USA 103(38):14080-14085 (Pubitemid 44452983)
6. Riggs AD, Xiong Z (2004) Methylation and epigenetic fi delity. Proc Natl Acad Sci USA 101(1):4-5
7. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6):915-926
8. Lei H, Oh SP, Okano M et al (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122(10):3195-3205
9. Li E (2002) Chromatin modi fi cation and epigenetic reprogramming in mammalian development. Nat Rev Genet 3(9):662-673 (Pubitemid 34984255)
10. Yoder JA, Walsh CP, Bestor TH (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13(8):335-340 (Pubitemid 27309911)
11. Gonzalo S, Jaco I, Fraga MF et al (2006) DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8(4):416-424
12. Xu GL, Bestor TH, Bourc'his D et al (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402(6758): 187-191
13. Guo G, Wang W, Bradley A (2004) Mismatch repair genes identi fi ed using genetic screens in Blm-deficient embryonic stem cells. Nature 429(6994):891-895 (Pubitemid 38843302)
14. Kim M, Trinh BN, Long TI, Oghamian S, Laird PW (2004) Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res 32(19): 5742-5749 (Pubitemid 39619157)
15. Wang KY, James Shen CK (2004) DNA methyltransferase Dnmt1 and mismatch repair. Oncogene 23(47):7898-7902
16. Dion V, Lin Y, Hubert L Jr, Waterland RA, Wilson JH (2008) Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline. Hum Mol Genet 17(9):1306-1317 (Pubitemid 351566967)
17. Loughery JE, Dunne PD, O'Neill KM, Meehan RR, McDaid JR, Walsh CP (2011) DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage response. Hum Mol Genet 20(16): 3241-3255
18. Karpf AR, Matsui S (2005) Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65(19):8635-8639 (Pubitemid 41377349)
19. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461(7267):1071-1078
20. Jacinto FV, Esteller M (2007) Mutator pathways unleashed by epigenetic silencing in human cancer. Mutagenesis 22(4):247-253 (Pubitemid 47216613)
21. Ha K, Lee GE, Palii SS et al (2011) Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery. Hum Mol Genet 20(1):126-140
22. Milutinovic S, Zhuang Q, Niveleau A, Szyf M (2003) Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 278(17):14985-14995 (Pubitemid 36799830)
23. Unterberger A, Andrews SD, Weaver IC, Szyf M (2006) DNA methyltransferase 1 knockdown activates a replication stress checkpoint. Mol Cell Biol 26(20):7575-7586 (Pubitemid 44547707)
24. Mortusewicz O, Schermelleh L, Walter J, Cardoso MC, Leonhardt H (2005) Recruitment of DNA methyltransferase I to DNA repair sites. Proc Natl Acad Sci USA 102(25):8905-8909 (Pubitemid 40881051)
25. Laghi L, Bianchi P, Malesci A (2008) Differences and evolution of the methods for the assessment of microsatellite instability. Oncogene 27(49):6313-6321
26. Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74:681-710 (Pubitemid 40995521)
27. Raschle M, Dufner P, Marra G, Jiricny J (2002) Mutations within the hMLH1 and hPMS2 subunits of the human MutLalpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSalpha. J Biol Chem 277(24):21810-21820 (Pubitemid 34952333)
28. Kantelinen J, Kansikas M, Korhonen MK et al (2010) MutSbeta exceeds MutSalpha in dinucleotide loop repair. Br J Cancer 102(6):1068-1073
29. Thibodeau SN, French AJ, Cunningham JM et al (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58(8):1713-1718 (Pubitemid 28215098)
30. Viswanathan M, Tsuchida N, Shanmugam G (2003) Promoter hypermethylation pro fi le of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105(1):41-46 (Pubitemid 36418483)
31. Kim HG, Lee S, Kim DY et al (2010) Aberrant methylation of DNA mismatch repair genes in elderly patients with sporadic gastric carcinoma: A comparison with younger patients. J Surg Oncol 101(1):28-35
32. Brucher BL, Geddert H, Langner C et al (2006) Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel. Int J Cancer 119(6):1298-1302 (Pubitemid 44258803)
33. Wang YC, Lu YP, Tseng RC et al (2003) Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest 111(6):887-895
34. Murphy MA, Wentzensen N (2011) Frequency of mismatch repair deficiency in ovarian cancer: a systematic review. Int J Cancer 129:1914-1922
35. Seedhouse CH, Das-Gupta EP, Russell NH (2003) Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia. Leukemia 17(1):83-88 (Pubitemid 36175892)
36. Lenz G, Hutter G, Hiddemann W, Dreyling M (2004) Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia. Ann Hematol 83(10):628-633 (Pubitemid 39317487)
37. Nomdedeu JF, Perea G, Estivill C et al (2005) Microsatellite instability is not an uncommon fi nding in adult de novo acute myeloid leukemia. Ann Hematol 84(6):368-375 (Pubitemid 40823350)
38. Taw fi k HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011) Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Am J Otolaryngol 32(6):528-36
39. Lahtz C, Pfeifer GP (2011) Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol 3(1):51-58
40. Valle L, Carbonell P, Fernandez V et al (2007) MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin Genet 71(3):232-237 (Pubitemid 46322661)
41. Gazzoli I, Loda M, Garber J, Syngal S, Kolodner RD (2002) A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability- high tumor. Cancer Res 62(14):3925-3928 (Pubitemid 34791053)
42. Herman JG, Umar A, Polyak K et al (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95(12):6870-6875 (Pubitemid 28278073)
43. Nakagawa H, Nuovo GJ, Zervos EE et al (2001) Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 61(19):6991-6995 (Pubitemid 32946483)
44. Kuismanen SA, Holmberg MT, Salovaara R et al (1999) Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci USA 96(22): 12661-12666 (Pubitemid 29513559)
45. Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ, Bodmer WF (1999) Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Proc Natl Acad Sci USA 96(18):10296-10301 (Pubitemid 29422552)
46. Auclair J, Vaissiere T, Desseigne F et al (2011) Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles. Genes Chromosomes Cancer 50(3):178-185
47. Zhang H, Zhang S, Cui J, Zhang A, Shen L, Yu H (2008) Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Aust N Z J Obstet Gynaecol 48(5):505-509
48. Vlaykova T, Mitkova A, Stancheva G et al (2011) Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer. J BUON 16(2):265-273
49. Nagasaka T, Rhees J, Kloor M et al (2010) Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. Cancer Res 70(8):3098-3108
50. Ligtenberg MJ, Kuiper RP, Chan TL et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 41(1):112-117
51. Moelans CB, Verschuur-Maes AH, van Diest PJ (2011) Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. J Pathol 225(2):222-231
52. David SS, O'Shea VL, Kundu S (2007) Base-excision repair of oxidative DNA damage. Nature 447(7147):941-950 (Pubitemid 46975761)
53. Peng B, Hurt EM, Hodge DR, Thomas SB, Farrar WL (2006) DNA hypermethylation and partial gene silencing of human thymine- DNA glycosylase in multiple myeloma cell lines. Epigenetics 1(3):138-145
54. Howard JH, Frolov A, Tzeng CW et al (2009) Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biol Ther 8(1):94-100
55. Guan H, Ji M, Hou P et al (2008) Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 113(2):247-255
56. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411(6835):366-374 (Pubitemid 32467046)
57. Yang J, Xu Z, Li J et al (2010) XPC epigenetic silence coupled with p53 alteration has a signi fi cant impact on bladder cancer outcome. J Urol 184(1):336-343
58. Chen HY, Shao CJ, Chen FR, Kwan AL, Chen ZP (2010) Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas. Int J Cancer 126(8):1944-1954
59. Liu WB, Ao L, Cui ZH et al (2011) Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis. Biochem Biophys Res Commun 408(4):595-601
60. Jiang J, Liang X, Zhou X et al (2010) DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies. J Thorac Oncol 5(11):1741-1747
61. Wang P, Tang JT, Peng YS, Chen XY, Zhang YJ, Fang JY (2010) XRCC1 downregulated through promoter hypermethylation is involved in human gastric carcinogenesis. J Dig Dis 11(6):343-351
62. Peng B, Hodge DR, Thomas SB et al (2005) Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem 280(6):4182-4187 (Pubitemid 40288583)
63. Moynahan ME, Jasin M (2010) Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 11(3):196-207
64. Mazon G, Mimitou EP, Symington LS. SnapShot: homologous recombination in DNA double- strand break repair. Cell . 2010;142(4):646, 646.e1.
65. Esteller M, Silva JM, Dominguez G et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92(7):564-569 (Pubitemid 30212318)
66. Esteller M, Risques RA, Toyota M et al (2001) Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 61(12): 4689-4692 (Pubitemid 32691877)
67. Baldwin RL, Nemeth E, Tran H et al (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60(19):5329-5333
68. Bernal C, Vargas M, Ossandon F et al (2008) DNA methylation pro fi le in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis. Biol Res 41(3):303-315
69. Cabello MJ, Grau L, Franco N et al (2011) Multiplexed methylation pro fi les of tumor suppressor genes in bladder cancer. J Mol Diagn 13(1):29-40
70. Lee MN, Tseng RC, Hsu HS et al (2007) Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer. Clin Cancer Res 13(3):832-838
71. Esteller M, Fraga MF, Guo M et al (2001) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 10(26):3001-3007 (Pubitemid 34083486)
72. Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11(10): 1226-1241 (Pubitemid 27235356)
73. Kee Y, D'Andrea AD (2010) Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 24(16):1680-1694
74. Meier D, Schindler D (2011) Fanconi anemia core complex gene promoters harbor conserved transcription regulatory elements. PLoS One 6(8):e22911
75. Hess CJ, Ameziane N, Schuurhuis GJ et al (2008) Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia. Cell Oncol 30(4):299-306 (Pubitemid 352032906)
76. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT (2004) Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 23(4):1000-1004 (Pubitemid 38250946)
77. Narayan G, Arias-Pulido H, Nandula SV et al (2004) Promoter hypermethylation of FANCF: disruption of Fanconi anemia-BRCA pathway in cervical cancer. Cancer Res 64(9): 2994-2997 (Pubitemid 38581394)
78. Lim SL, Smith P, Syed N et al (2008) Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer. Br J Cancer 98(8):1452-1456 (Pubitemid 351543586)
79. Pegg AE, Dolan ME, Moschel RC (1995) Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51:167-223
80. Gerson SL (2004) MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4(4):296-307 (Pubitemid 38525285)
81. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59(4):793-797 (Pubitemid 29086728)
82. Weller M, Stupp R, Reifenberger G et al (2010) MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 6(1):39-51
83. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR (2001) Methylation of O-6- methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with lowlevel DNA microsatellite instability. Cancer Res 61(3):827-830 (Pubitemid 32174386)
84. Park TJ, Han SU, Cho YK, Paik WK, Kim YB, Lim IK (2001) Methylation of O(6)- methylguanine-DNA methyltransferase gene is associated signi fi cantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92(11):2760-2768 (Pubitemid 33091912)
85. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54(18): 4855-4878 (Pubitemid 24289415)
86. Zhang YJ, Chen Y, Ahsan H et al (2003) Inactivation of the DNA repair gene O6-methylguanine- DNA methyltransferase by promoter hypermethylation and its relationship to a fl atoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma. Int J Cancer 103(4): 440-444 (Pubitemid 36020217)
87. Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA (2001) O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in nonsmall cell lung cancer. Cancer Res 61(22):8113-8117 (Pubitemid 33091600)
88. Zhang L, Lu W, Miao X, Xing D, Tan W, Lin D (2003) Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 24(6):1039-1044 (Pubitemid 36827255)
89. Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H (2001) Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C -> A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis 22(10):1715-1719 (Pubitemid 32952152)
90. Sabharwal A, Middleton MR (2006) Exploiting the role of O6-methylguanine-DNAmethyltransferase (MGMT) in cancer therapy. Curr Opin Pharmacol 6(4):355-363
91. Kitano K, Kim SY, Hakoshima T (2010) Structural basis for DNA strand separation by the unconventional winged-helix domain of RecQ helicase WRN. Structure 18(2):177-187
92. Opresko PL (2008) Telomere ResQue and preservation - roles for the Werner syndrome protein and other RecQ helicases. Mech Ageing Dev 129(1-2):79-90 (Pubitemid 351210677)
93. Agrelo R, Cheng WH, Setien F et al (2006) Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci USA 103(23):8822-8827 (Pubitemid 43878103)
94. Kawasaki T, Ohnishi M, Suemoto Y et al (2008) WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod Pathol 21(2):150-158 (Pubitemid 351172166)
95. Smith JA, Ndoye AM, Geary K, Lisanti MP, Igoucheva O, Daniel R (2010) A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4. Aging Cell 9(4):580-591
96. Polo SE, Jackson SP (2011) Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modi fi cations. Genes Dev 25(5):409-433
97. Harrison JC, Haber JE (2006) Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 40:209-235 (Pubitemid 44956785)
98. Lazzaro F, Giannattasio M, Puddu F et al (2009) Checkpoint mechanisms at the intersection between DNA damage and repair. DNA Repair (Amst) 8(9):1055-1067
99. Linding R, Jensen LJ, Ostheimer GJ et al (2007) Systematic discovery of in vivo phosphorylation networks. Cell 129(7):1415-1426 (Pubitemid 46962092)
100. Matsuoka S, Ballif BA, Smogorzewska A et al (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316(5828): 1160-1166 (Pubitemid 46877472)
101. Kim WJ, Vo QN, Shrivastav M, Lataxes TA, Brown KD (2002) Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 21(24):3864-3871 (Pubitemid 34620854)
102. Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene 23(58): 9432-9437 (Pubitemid 40069676)
103. Ai L, Vo QN, Zuo C et al (2004) Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev 13(1):150-156 (Pubitemid 38116634)
104. Bartek J, Falck J, Lukas J (2001) CHK2 kinase - a busy messenger. Nat Rev Mol Cell Biol 2(12):877-886 (Pubitemid 33674087)
105. Bell DW, Varley JM, Szydlo TE et al (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286(5449):2528-2531
106. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3(5):421-429 (Pubitemid 38340288)
107. Kato N, Fujimoto H, Yoda A et al (2004) Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. Cell Death Differ 11(Suppl 2):S153-161
108. Kim DS, Kim MJ, Lee JY et al (2009) Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features. Lung Cancer 65(2):247-250
109. Wang H, Wang S, Shen L et al (2010) Chk2 down-regulation by promoter hypermethylation in human bulk gliomas. Life Sci 86(5-6):185-191
110. Sullivan A, Yuille M, Repellin C et al (2002) Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene 21(9):1316-1324 (Pubitemid 34214497)
111. Williams LH, Choong D, Johnson SA, Campbell IG (2006) Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers. Clin Cancer Res 12(23):6967-6972 (Pubitemid 44974490)
112. Jascur T, Boland CR (2006) Structure and function of the components of the human DNA mismatch repair system. Int J Cancer 119(9):2030-2035 (Pubitemid 44423658)
113. Loeb LA, Loeb KR, Anderson JP (2003) Multiple mutations and cancer. Proc Natl Acad Sci USA 100(3):776-781 (Pubitemid 36183906)
114. Lin Y, Wilson JH (2009) Diverse effects of individual mismatch repair components on transcription- induced CAG repeat instability in human cells. DNA Repair (Amst) 8(8):878-885
115. Lin Y, Dion V, Wilson JH (2006) Transcription promotes contraction of CAG repeat tracts in human cells. Nat Struct Mol Biol 13(2):179-180 (Pubitemid 43214723)
116. Karran P (2006) Thiopurines, DNA damage, DNA repair and therapy-related cancer. Br Med Bull 79-80:153-170
117. Bellacosa A, Cicchillitti L, Schepis F et al (1999) MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci USA 96(7):3969-3974 (Pubitemid 29169020)
118. Ruzov A, Shorning B, Mortusewicz O, Dunican DS, Leonhardt H, Meehan RR (2009) MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos. Development 136(13):2277-2286
119. Cortellino S, Turner D, Masciullo V et al (2003) The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci USA 100(25):15071-15076 (Pubitemid 37518018)
120. Boland MJ, Christman JK (2008) Characterization of Dnmt3b:thymine-DNA glycosylase interaction and stimulation of thymine glycosylase-mediated repair by DNA methyltransferase(s) and RNA. J Mol Biol 379(3):492-504
121. Li YQ, Zhou PZ, Zheng XD, Walsh CP, Xu GL (2007) Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair. Nucleic Acids Res 35(2): 390-400 (Pubitemid 46237388)
122. Kimura H, Shiota K (2003) Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem 278(7):4806-4812 (Pubitemid 36800984)
123. Jackson-Grusby L, Beard C, Possemato R et al (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27(1):31-39 (Pubitemid 32044515)
124. Flores-Rozas H, Clark D, Kolodner RD (2000) Proliferating cell nuclear antigen and Msh2p- Msh6p interact to form an active mispair recognition complex. Nat Genet 26(3):375-378
125. Iyer RR, Pohlhaus TJ, Chen S et al (2008) The MutSalpha-proliferating cell nuclear antigen interaction in human DNA mismatch repair. J Biol Chem 283(19):13310-13319
126. Plotz G, Welsch C, Giron-Monzon L et al (2006) Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair. Nucleic Acids Res 34(22):6574-6586 (Pubitemid 46017952)
127. Kleczkowska HE, Marra G, Lettieri T, Jiricny J (2001) hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci. Genes Dev 15(6):724-736 (Pubitemid 32244901)
128. Umar A, Buermeyer AB, Simon JA et al (1996) Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87(1):65-73 (Pubitemid 26337391)
129. Chen F, Arseven OK, Cryns VL (2004) Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis. J Biol Chem 279(26):27542-27548 (Pubitemid 38812595)
130. Kim MY, Zhang T, Kraus WL (2005) Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev 19(17):1951-1967
131. Bischof O, Galande S, Farzaneh F, Kohwi-Shigematsu T, Campisi J (2001) Selective cleavage of BLM, the bloom syndrome protein, during apoptotic cell death. J Biol Chem 276(15): 12068-12075
132. Wang J, Pabla N, Wang CY, Wang W, Schoenlein PV, Dong Z (2006) Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53. Am J Physiol Renal Physiol 291(6):F1300-1307 (Pubitemid 44887243)
133. Knox JD, Araujo FD, Bigey P et al (2000) Inhibition of DNA methyltransferase inhibits DNA replication. J Biol Chem 275(24):17986-17990 (Pubitemid 30414744)
134. Bartek J, Lukas J (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 13(6):738-747 (Pubitemid 33042735)
135. Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1(3):179-186
136. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410(6830):842-847 (Pubitemid 32303786)
137. Maser RS, Mirzoeva OK, Wells J et al (2001) Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol 21(17):6006-6016 (Pubitemid 32743151)
138. Hardy CF (1997) Identi fi cation of Cdc45p, an essential factor required for DNA replication. Gene 187(2):239-246 (Pubitemid 27140255)
139. Rhee I, Bachman KE, Park BH et al (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416(6880):552-556 (Pubitemid 34288859)
140. Ting AH, Jair KW, Suzuki H, Yen RW, Baylin SB, Schuebel KE (2004) CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat Genet 36(6):582-584 (Pubitemid 38715984)
141. Chen T, Hevi S, Gay F et al (2007) Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 39(3):391-396 (Pubitemid 46328497)
142. Brown KD, Robertson KD (2007) DNMT1 knockout delivers a strong blow to genome stability and cell viability. Nat Genet 39(3):289-290 (Pubitemid 46328481)
143. Canman CE, Lim DS, Cimprich KA et al (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281(5383):1677-1679 (Pubitemid 28435584)
144. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421(6922):499-506 (Pubitemid 36168436)
145. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395(6697):89-93 (Pubitemid 28420236)
146. Palii SS, Van Emburgh BO, Sankpal UT, Brown KD, Robertson KD (2008) DNA methylation inhibitor 5-Aza-2′ -deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol 28(2):752-771
147. Spada F, Haemmer A, Kuch D et al (2007) DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells. J Cell Biol 176(5):565-571 (Pubitemid 46333972)